文献速递静脉血栓栓塞

使用结合篮式与旋转血栓切除双重作用机制装置单次机械血栓切除术治疗髂股深静脉血栓

Single-session mechanical thrombectomy for iliofemoral deep vein thrombosis using a dual mechanism of action device combining basket and rotational thrombectomy.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2024-03-04

这项前瞻性、非随机、多中心、首次人体研究纳入19例急性髂股深静脉血栓患者,评估Pounce静脉血栓切除系统治疗后12个月内的安全性和性能。主要终点为所有患者达到完全或近完全血栓清除(SIR II或III级),无大出血或装置相关不良事件;16例(84.2%)未使用溶栓药物。静脉疾病严重程度和生活质量均有改善。

要点

  • 19例急性髂股深静脉血栓患者中,全部达到完全或近完全血栓清除(SIR II或III级)。
  • 16例(84.2%)术中未接受溶栓药物治疗,无大出血或装置相关不良事件。
  • 血栓后综合征(Villalta评分>4)基线17/19例(89.5%),6个月4/13例(30.8%),12个月2/11例(18.2%)。

核心结论

  • Pounce装置对急性髂股深静脉血栓患者的血栓清除安全有效,初步结果显示静脉疾病严重程度和患者生活质量改善。

研究设计与样本

  • 前瞻性、非随机、多中心、首次人体研究,纳入19例急性髂股深静脉血栓患者,评估Pounce静脉血栓切除系统治疗后≤12个月的安全性和性能。

主要发现

  • 主要终点完全或近完全血栓清除(SIR II或III级)在所有患者中达成,所有装置相关安全性终点均满足,无大出血或装置相关不良事件。
  • 19例中16例(84.2%)术中未接受溶栓药物。
  • 血栓后综合征(Villalta评分>4)基线17/19例(89.5%),6个月随访时4/13例(30.8%),12个月时2/11例(18.2%)。
  • 静脉临床严重程度评分中位数从基线8.5(IQR 7-10)降至术后1个月4(IQR 2-4),P<.001;6个月为2(IQR 2-5),12个月为2(IQR 1.5-3)。
  • 静脉功能不全流行病学和经济研究-生活质量问卷评分中位数从基线57(IQR 53.5-74)提高39至术后1个月96(IQR 86-101),P<.001;6个月为99(IQR 75-103),12个月为98(IQR 94.5-100)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Interventional treatments for acute iliofemoral deep vein thrombosis (DVT) remain controversial after publication of the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) study. Interventions have been shown to reduce post-thrombotic syndrome severity and improve quality of life in DVT patients, but have been accompanied by risk of major bleeding from thrombolytics. We describe thrombus removal using a novel combined basket-rotational thrombectomy device that minimizes the need for thrombolytics or repeat procedures. METHODS: The aim of this prospective, nonrandomized, multicenter, first-in-human study of 19 patients with acute iliofemoral DVT was to evaluate the safety and performance of the Pounce venous thrombectomy system ≤12 months after treatment. The primary performance end point was defined as procedural success through achievement of Society of Interventional Radiology (SIR) grade II lysis in treated vessels with freedom from procedural adverse events. Secondary end points included venous disease severity assessments using the Villalta scale and the Venous Clinical Severity Score, patient quality-of-life measurement using the Venous Insufficiency Epidemiological and Economic Study-Quality of Life questionnaire, and calf circumference measurements taken at baseline, 24 hours, and 1 month. RESULTS: The primary end point of complete or near-complete thrombus removal (Society of Interventional Radiology grade II or III) was achieved in all patients. All study device-related safety end points were met, with no major bleeding or device-related adverse events. Of the 19 patients treated, 16 (84.2%) did not receive thrombolytics during the procedure. Post-thrombotic syndrome (Villalta scale >4) was identified in 17 of 19 patients (89.5%) at baseline, 4 of 13 patients (30.8%) available for follow-up at 6 months, and 2 of 11 patients (18.2%) at 12 months. The median Venous Clinical Severity Score decreased (P < .001) from 8.5 (interquartile range [IQR], 7-10) at baseline to 4 (IQR, 2-4) at 1 month after the procedure and was similar at 6 months (2; IQR, 2-5) and 12 months (2; IQR, 1.5-3) after the procedure. The median Venous Insufficiency Epidemiological and Economic Study-Quality of Life questionnaire score improved (P < .001) by 39 from baseline (57; IQR, 53.5-74) to 1 month (96; IQR, 86-101) after the procedure, and remained high at 6 months (99; IQR, 75-103) and 12 months (98; IQR, 94.5-100). The median calf circumference decreased (P = .089) from 39 cm (IQR, 35-47.8 cm) at baseline to 36 cm (IQR, 32.5-40.5 cm) at 24 hours after the procedure and was 34.5 cm (IQR, 33.2-38.5 cm) at 1 month. CONCLUSIONS: The Pounce device is safe and effective for removal the of thrombus in patients with acute iliofemoral DVT. Initial results demonstrate improvements in venous disease severity and patient quality of life.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Black SA, Thulasidasan N, Benton L, et al. Single-session mechanical thrombectomy for iliofemoral deep vein thrombosis using a dual mechanism of action device combining basket and rotational thrombectomy. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38447877. doi:10.1016/j.jvsv.2024.101866

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。